How Often Can You Get a Kenalog Shot for Allergies?

Most doctors will not give a Kenalog (triamcinolone acetonide) shot for allergies more than two or three times a year, with a minimum of roughly three months between injections. Some practitioners are even more conservative, limiting patients to a single injection per allergy season. The reason comes down to the drug’s pharmacology and a growing appreciation of its cumulative side effects, which has made many allergists reluctant to use it at all when safer alternatives exist.

How a Single Kenalog Shot Works in Your Body

Kenalog is a depot corticosteroid, meaning the drug is injected into muscle tissue and then slowly released into the bloodstream over weeks. That slow release is what makes a single shot effective for so long compared with taking a pill. The triamcinolone acetonide molecule has low solubility in blood, absorbs slowly from the injection site, and is cleared through the kidneys at a low rate, all of which contribute to its extended duration of action.

For allergy sufferers, that typically translates into three to six weeks of meaningful symptom relief from a single intramuscular injection. The corticosteroid suppresses the inflammatory cascade that drives sneezing, nasal congestion, and itchy eyes during pollen season. Because the drug lingers in tissue and blood for weeks, you cannot simply “flush it out” if side effects appear. Once it is injected, you are committed to its full duration, good or bad.

The Three-Month Rule and Why It Exists

The general spacing guideline of at least three months between injections is not based on how long the allergy relief lasts. It is based on how long the drug’s systemic effects persist. Research shows that both intra-articular and intramuscular corticosteroid injections produce measurable systemic effects for weeks after administration, and complications including Cushing syndrome, loss of bone density, infection, and elevated blood sugar have been associated with their use.² Stacking a second injection on top of residual systemic steroid exposure from the first one multiplies that risk.

In practice, this means the three-month interval is a floor, not a target. If your allergy season is six weeks long and one shot covers it, you are done for the year. If you have a spring tree pollen season and a fall ragweed season separated by several months, two shots a year might be reasonable. Where doctors draw the line is when patients ask for four or five shots to cover overlapping seasons, because the cumulative steroid dose at that point begins to resemble a course of oral corticosteroids with all the attendant risks.

Adrenal Suppression Is the Biggest Concern

Your adrenal glands produce cortisol, the body’s natural steroid. When you flood your system with a synthetic corticosteroid like triamcinolone, the adrenal glands dial back their own production because the body senses it has plenty. With repeated or high doses, the glands can essentially shut down temporarily, a condition called adrenal insufficiency. The unsettling part is that this does not require long-term use. Research has documented that clinically significant adrenal suppression can occur even after a single injection of triamcinolone acetonide.³

Adrenal suppression matters because when your body stops making its own cortisol and the injected steroid eventually wears off, you can be left with dangerously low cortisol levels. Symptoms range from fatigue and weakness to dizziness, nausea, and in severe cases an adrenal crisis that requires emergency treatment. The more frequently you get Kenalog shots, the longer and more deeply your adrenal glands are suppressed, and the longer it takes them to recover between doses. This is the core pharmacological reason doctors insist on spacing injections out and limiting the total number per year.

Other Side Effects That Accumulate

Adrenal suppression gets the most clinical attention, but it is far from the only systemic side effect. A review of corticosteroid injection side effects lists adrenal suppression alongside facial flushing, hypertension, elevated blood sugar, and osteoporosis as recognized systemic complications.⁴ Each of these deserves a closer look, because some of them affect people who might not think of themselves as being at risk.

Blood sugar spikes: Even a single dose of a corticosteroid can affect glucose tolerance within hours. Research on healthy young adults showed significant effects on glucose tolerance after a single steroid dose.⁵ For someone with diabetes or prediabetes, a Kenalog shot can send blood sugar levels soaring for days or even weeks. Multiple shots per year compound this disruption.
Bone density loss: Corticosteroids suppress bone formation. The same study in healthy adults found that bone formation markers dropped significantly within a day of steroid treatment and remained suppressed for a week.⁵ Over time, repeated injections chip away at bone density, raising fracture risk. People with existing osteoporosis or osteopenia are especially vulnerable.
Eye problems: Systemic corticosteroids can contribute to cataracts, glaucoma, eye infections, and delayed corneal healing.⁶ These risks are dose-dependent, so fewer shots means less total exposure and lower risk. Anyone with a family history of glaucoma or existing elevated eye pressure should mention this before getting a Kenalog injection.
Skin and tissue changes: Repeated steroid injections can cause thinning of skin near the injection site, stretch marks, and local fat atrophy that leaves visible dimpling. These cosmetic effects are sometimes permanent.

None of these side effects are guaranteed after one or two shots. The concern is cumulative exposure. A patient who gets a single Kenalog injection during a brutal spring pollen season faces a very different risk profile from someone getting four injections a year for a decade.

Who Should Think Twice Before Getting Kenalog

Certain groups face disproportionate risks from intramuscular corticosteroid injections. If you have diabetes, even well-controlled diabetes, the blood sugar effects of Kenalog can be difficult to manage and may persist for weeks. You should expect to monitor your glucose more closely and possibly adjust your medication after a shot, which means your endocrinologist or primary care doctor needs to be in the loop.

People with osteoporosis or significant osteopenia should generally avoid repeated Kenalog injections. The bone formation suppression is measurable even in young, healthy people, so for someone already losing bone density the risk-benefit math tilts quickly away from the injection. Postmenopausal women who have not had a bone density scan might want one before committing to yearly steroid injections for allergy management.

Anyone with a history of glaucoma, elevated intraocular pressure, or posterior subcapsular cataracts should approach systemic steroids with caution. The ocular effects of corticosteroids are well-documented and can be irreversible.⁶ If your ophthalmologist has flagged steroid use as a concern, that applies to Kenalog injections, not just steroid eye drops.

People with active infections, poorly controlled hypertension, or peptic ulcer disease also face elevated risks from systemic corticosteroids. And if you have already received corticosteroids by any other route recently, whether oral prednisone for an asthma flare, an epidural steroid injection for back pain, or a cortisone shot in your knee, all of that steroid exposure stacks. Your doctor needs to know about every steroid you have received in the past several months before deciding whether a Kenalog shot is safe.

Why Many Allergists Have Moved Away From Kenalog

If you have had trouble getting a Kenalog shot from an allergist in recent years, it is not because they forgot about it. Major allergy and immunology guidelines recommend against routine intramuscular corticosteroid injections for seasonal allergic rhinitis, reserving them only for the most severe and treatment-resistant cases where other options have failed.⁷ The shift reflects a broader recognition that the risk-benefit balance does not favor a systemic injection when localized treatments can achieve comparable symptom control without the systemic side effects.

This is a genuine point of tension in clinical practice. Patients who have had a Kenalog shot and experienced dramatic relief often feel strongly that nothing else works as well. And they are not wrong that the subjective experience is powerful: a single shot can eliminate allergy symptoms for weeks, which feels miraculous compared with the daily discipline of nasal sprays and pills. But the clinical question is not whether Kenalog works. It clearly does. The question is whether it works well enough better than safer alternatives to justify the side effects. For most patients with seasonal allergies, current evidence and guidelines say no.

What Works Instead

The first-line treatments that guidelines recommend ahead of Kenalog are not exotic or inconvenient. Intranasal corticosteroid sprays like fluticasone and mometasone deliver a steroid directly to the nasal tissue where allergic inflammation occurs, with far less systemic absorption than an intramuscular injection. The steroid dose in a daily nasal spray is a fraction of what a Kenalog shot delivers to your entire body. These sprays work best when started a week or two before your allergy season begins and used consistently, not just on bad days.

Second-generation antihistamines like cetirizine, loratadine, and fexofenadine are effective for itching, sneezing, and runny nose with minimal drowsiness. Combining a daily nasal steroid with a daily antihistamine covers most people through a typical allergy season. For eye symptoms specifically, antihistamine eye drops or mast cell stabilizer drops target the problem locally without any systemic steroid exposure at all.

For severe, persistent allergic rhinitis that does not respond to sprays and pills, allergen immunotherapy is the only treatment that actually modifies the underlying immune response rather than just suppressing symptoms. Immunotherapy involves gradually exposing the immune system to increasing amounts of the allergen, either through regular injections over several years or sublingual tablets taken daily. The catch, as allergy guidelines acknowledge, is that immunotherapy cannot be started during peak pollen season, so it requires advance planning.⁷ This timing gap is one reason patients end up asking for a Kenalog shot: they show up miserable in April, and their doctor cannot start immunotherapy until the fall.

When a Kenalog Shot Might Still Be Reasonable

There are genuine clinical scenarios where a Kenalog shot remains defensible. If you have tried maximum-dose nasal steroids, oral antihistamines, and possibly even a short course of oral prednisone and are still miserable during a severe allergy season, a single intramuscular injection to get through the worst few weeks is a reasonable option for an otherwise healthy person. The key details matter: a single shot, in a person without contraindications, as a bridge while longer-term treatment strategies are being arranged.

The shot also makes practical sense for people who simply cannot manage daily medication routines due to cognitive impairment, severe disability, or homelessness, where the alternative is no treatment at all. A single injection that provides weeks of relief removes the compliance burden entirely. In these situations, the systemic risks of one or two yearly injections may be outweighed by the functional benefit of being able to breathe and sleep.

What is harder to justify is the pattern of three or four Kenalog shots every year, year after year, in a patient who has never seriously tried nasal steroids or immunotherapy. That pattern reflects habit or convenience rather than medical necessity, and the cumulative steroid load over a decade can produce real harm to bones, blood sugar regulation, adrenal function, and eyes.

What to Discuss With Your Doctor Before the Injection

If you and your doctor decide a Kenalog shot is appropriate, a few practical details are worth clarifying. First, ask about the dose. Kenalog comes in 40 mg and 80 mg formulations for intramuscular injection. Some doctors use 40 mg for seasonal allergies, which produces fewer systemic effects than the 80 mg dose. The lower dose may not last quite as long, but for a defined allergy season of four to six weeks, it is often sufficient.

Second, ask explicitly how long you should wait before getting another injection if this one wears off before your season ends. Having that conversation before the shot establishes expectations and prevents the awkward situation of calling back three weeks later begging for another dose.

Third, mention every other steroid you have used recently. This includes oral prednisone, inhaled corticosteroids for asthma (though these have minimal systemic absorption), steroid creams used over large skin areas, and cortisone injections in joints. Your doctor cannot assess your cumulative steroid exposure if they do not know about all of these.

Finally, if you have been getting Kenalog shots annually for several years and have never had a bone density scan, ask whether one is warranted. The bone formation suppression caused by repeated corticosteroid exposure can be silent until a fracture occurs.² Catching bone density loss early gives you a chance to intervene before a fracture happens, whether that means stopping the injections, starting bone-protective medication, or both.

The Facial Flushing and Other Immediate Reactions

Some side effects of Kenalog show up within hours, not months. Facial flushing is among the most common and most alarming to patients who are not expecting it. Your face, neck, and chest can turn bright red and feel warm for a day or two after the injection. It looks dramatic but is generally harmless and resolves on its own. Some people also experience a temporary increase in appetite, mood changes (including irritability or a jittery, wired feeling), and difficulty sleeping for the first few nights.

Menstrual irregularities are another frequently reported effect. A single Kenalog shot can delay or disrupt your next period, sometimes by a week or more. This is not dangerous, but it catches many people off guard, especially if nobody mentioned it ahead of time. If you are tracking your cycle for fertility purposes, the timing of a Kenalog shot is worth planning carefully.

At the injection site itself, you might notice soreness, a temporary dip or dimple in the skin from local fat atrophy, or discoloration. These local effects are more common with superficial injections and are usually avoidable when the shot is given deep into the gluteal muscle as intended. If you notice a lasting dimple at the injection site, mention it at your next visit, as it could indicate the injection was placed too superficially and the technique should be adjusted next time.

1
Springer Link / Clin Pharmacokinet. Enigma of Intramuscular Triamcinolone Acetonide (Kenalog®) Efficacy
2
PubMed. Systemic Absorption and Side Effects of Locally Injected Glucocorticoids
3
PubMed. Secondary adrenal insufficiency after local injections of triamcinolone acetonide
4
PubMed. Local and Systemic Side Effects of Corticosteroid Injections for Musculoskeletal Indications
5
European Journal of Endocrinology. Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals
6
Dermatologic Clinics. Ocular Effects of Topical and Systemic Steroids
7
PubMed Central. Intramuscular corticosteroid injections in seasonal allergic rhinitis: A systematic review